Skip to content

Author

Di Li

We have 2 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

STARD3NL as a prognostic marker related to an immunosuppressive tumor microenvironment in hepatocellular carcinoma

It is indicated that STARD3NL may have value as a prognostic biomarker associated with an immunosuppressive tumor microenvironment and patients with increased STARD3NL expression had poorer survival and multivariable analysis supported STARD3NL as an independent risk factor.

Di Li, Zi-Yu Liu, Lihe Xie et al. · 0 citations
Open access Jul 2026

NTMT1 (METTL11A) promotes MYC-dependent proliferation and downstream HLA-A suppression in cervical cancer

Findings identify NTMT1 as a candidate regulatory node associated with MYC activation and downstream HLA-A suppression, warranting further mechanistic and in-vivo investigation, and highlighting NTMT1 as a promising candidate for future therapeutic investigation.

Jin-Ling Zhang, Chen Chen, Huibin Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.